AnandRathi

Bafna Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 17 Sept 2026
316.20
+6.20 (+2.00%)

Bafna Pharmaceuticals Ltd (Bafna Pharma.) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹748 crore.

Bafna Pharmaceuticals Ltd Overview

Market cap₹748 Crs
Volume3,225
Prev. Close₹310.00
Year range₹95.00 - ₹318.00
ISININE878I01022

Bafna Pharmaceuticals Ltd Fundamentals

ROCE(TTM)10.63%
P/E Ratio (TTM)96.11
P/B Ratio7.78
Debt to Equity0.39
ROE11.54%
EPS (TTM)3.29
Dividend Yield0.00%
Book Value40.64
Profit Margin5.46%
Operating Margin3.70%

Bafna Pharmaceuticals Ltd Historical Performance

1 Month Return22.94%
6 Month Return192.24%
3 Year Return252.31%
3 Month Return100.63%
1 Year Return153.67%
5 Year Return145.12%

Bafna Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research